Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized prediction and regulation of 5-fluorouracil exposure
NL-OMON54497Phase 4Completed
- Sponsor
- Vrije University Medical Center
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fluorouracil in intestinal cancer, sponsored by Vrije University Medical Center. Started Feb 2020; status: completed.
02
Drugs
fluorouracil
03
Conditions
intestinal cancer
Beyond the preview
Go deeper on NL-OMON54497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54497.